The Impact of Comorbid Nasal Polyps on Real-World Mepolizumab Effectiveness in Patients with Severe Asthma: Results from the REALITI-A Study

被引：0
|
作者：
Liu, M. C. [1 ,2 ]
Bagnasco, D. [3 ]
Matucci, A. [4 ]
Pilette, C. [5 ,6 ]
Price, R. G. [7 ]
Maxwell, A. C. [8 ]
Cristancho, R. Alfonso [9 ]
Jakes, R. W. [10 ]
Yang, S. [9 ]
Howarth, P. [11 ]
Cheema, A. S. [12 ]
机构：
[1] Johns Hopkins Asthma & Allergy Ctr, Div Clin Immunol & Allergy, Baltimore, MD USA
[2] Johns Hopkins Asthma & Allergy Ctr, Div Pulm & Crit Care Med, Baltimore, MD USA
[3] Univ Genoa, Osped Policlin San Martino, DIMI Dept Internal Med, Allergy & Resp Dis, Genoa, Italy
[4] Univ Florence, Azienda Osped Univ Careggi, Immunoallergol Unit, Florence, Italy
[5] UCLouvain, Clin Univ St Luc, Dept Pulm Med, Brussels, Belgium
[6] UCLouvain, Inst Expt & Clin Res, Brussels, Belgium
[7] GSK, Biostat, Stevenage, Herts, England
[8] GSK, Real World Study Delivery, Value Evidence & Outcomes, Global Med, Stevenage, Herts, England
[9] GSK, Value Evidence & Outcomes, Collegeville, PA USA
[10] GSK, Epidemiol, London, England
[11] GSK, Specialty Care TA, Global Med, Brentford, England
[12] Alpha Med Res, Mississauga, ON, Canada
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4837
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Patient and Physician Perspectives on Mepolizumab Treatment in Severe Asthma: Data From the REALITI-A Study
    Lee, Jason
    Canonica, Giorgio
    Caruso, Cristiano
    Chaudhuri, Rekha
    Pilette, Charles
    Price, Robert
    Howarth, Peter
    Lee, F. Eun-Hyung
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB102 - AB102
  • [32] International, prospective study of mepolizumab in severe asthma: REALITI-A at 2yrs
    Caruso, C.
    Canonica, G. W.
    Patel, M.
    Smith, A.
    Liu, M. C.
    Alfonso-Cristancho, R.
    Price, R. G.
    Jakes, R. W.
    Demetriou, L.
    Valero, A.
    Pilette, C.
    Howarth, P.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [33] Real-world outcomes of patients with severe asthma treated with mepolizumab by baseline inhaled corticosteroid dose: Post hoc analysis of realiti-a at 2 years
    Smith, A.
    Patel, M.
    Caruso, C.
    Pilette, C.
    Welte, T.
    Alfonso-Cristancho, R.
    Price, R. G.
    Howarth, P.
    ALLERGY, 2023, 78 : 50 - 51
  • [34] The Clinical Benefit Of Mepolizumab Treatment Is Independent Of Baseline Maintenance Oral Corticosteroid Use: Results From The Real-World REALITI-A Study
    Liu, Mark
    Schleich, Florence
    Lee, Jason
    Pelaia, Girolamo
    Sanchez, Carlos Almonacid
    Heaney, Liam
    Alfonso-Cristancho, Rafael
    Jakes, Rupert
    Price, Robert
    Maxwell, Aoife
    Howarth, Peter
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB147 - AB147
  • [35] REAL-WORLD OUTCOMES WITH MEPOLIZUMAB IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA ACCORDING TO SMOKING HISTORY AND COPD STATUS AT ENROLLMENT: REALITI-A POST HOC ANALYSIS
    Bagnasco, Diego
    Hill, David G.
    Welte, Tobias
    Chaudhuri, Rekha
    Price, Robert
    Howarth, Peter
    CHEST, 2023, 164 (04) : 75A - 76A
  • [36] Clinical Remission Achievement in Severe Asthma Following Mepolizumab Treatment: Results From the REALITI-A Study at 2 Years
    Brusselle, G.
    Lougheed, M.
    Canonica, G.
    Munoz-Esquerre, M.
    Heaney, L.
    Price, R.
    Howarth, P.
    Raimondi, A.
    Gardiner, F.
    Chupp, G.
    Welte, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [37] Impact of mepolizumab in severe asthma with nasal polyps
    Tinoco, Eduarda M.
    Gigante, Ana R.
    Fernandes, Ana L.
    Cabrita, Bruno
    Santa, Catia
    Sucena, Ines
    Martins, Sara
    Machado, Daniela
    Franco, Ines
    Ladeira, Ines
    Pascoal, Ivone
    Lima, Ricardo
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [38] Effectiveness of mepolizumab in patients with severe eosinophilic asthma: results from real-world clinical practice in Finland
    Koistinen, Ville
    Kauppi, Paula
    Idanpaan-Heikkila, Juhana
    Veijalainen, Lauri
    Iso-Mustajarvi, Ilona
    Ylisaukko-Oja, Tero
    Mehtala, Juha
    Viinanen, Arja
    Kilpelainen, Maritta
    JOURNAL OF ASTHMA, 2022, 59 (12) : 2375 - 2385
  • [39] How Real-World Mepolizumab Users in the REALITI-A Study Relate to the Recruitment Criteria Applied in the Randomized, Placebo-Controlled Trials of Subcutaneous Mepolizumab in Severe Eosinophilic Asthma
    Ramos-Barbon, D.
    Bals, R.
    Crimi, N.
    Menzies, D.
    Pek, B.
    Pilette, C.
    Steven, G.
    Alfonso-Cristancho, R.
    Jakes, R.
    Maxwell, A. C.
    Price, R. G.
    Yang, S.
    Howarth, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [40] Real-World Effectiveness of Mepolizumab in Patients with Respiratory Comorbidities and Severe Asthma
    Hahn, B.
    Casale, T.
    Molfino, N.
    Silver, J.
    Bogart, M.
    Packnett, E.
    McMorrow, D.
    Wu, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
12345